{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:52:00Z","timestamp":1775199120303,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Controlled human hookworm infection (CHHI) is a central component of a proposed hookworm vaccination-challenge model (HVCM) to test the efficacy of candidate vaccines. Critical to CHHI is the manufacture of Necator americanus infective larvae (NaL3) according to current Good Manufacturing Practice (cGMP) and the determination of an inoculum of NaL3 that is safe and reliably induces patent infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>cGMP-grade NaL3 were produced for a phase 1 trial in 20 healthy, hookworm-na\u00efve adults in the United States, who received either 25 or 50 NaL3. Participants were monitored for 12\u201318 weeks postinfection for safety, tolerability, and patency of N. americanus infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Both NaL3 doses were well tolerated. Early manifestations of infection included pruritus, pain, and papulovesicular rash at the application site. Gastrointestinal symptoms and eosinophilia appeared after week 4 postinfection. The 50 NaL3 inoculum induced patent N. americanus infection in 90% of this dose group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The inoculum of 50 NaL3 was well tolerated and consistently induced patent N. americanus infection suitable for future HVCM trials.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration<\/jats:title>\n                  <jats:p>NCT01940757.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofy083","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T08:24:12Z","timestamp":1524126252000},"source":"Crossref","is-referenced-by-count":40,"title":["Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2789-0512","authenticated-orcid":false,"given":"David","family":"Diemert","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"},{"name":"Department of Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Brelsford","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlyn","family":"Leasure","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangzhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Zumer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naji","family":"Younes","sequence":"additional","affiliation":[{"name":"Milken Institute School of Public Health, The George Washington University, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Tropical Medicine, Texas Children\u2019s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rojelio","family":"Mejia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Tropical Medicine, Texas Children\u2019s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I","family":"Pritchard","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Hawdon","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M","family":"Bethony","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Tropical Medicine, Washington DC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"2020081004280604600_CIT0001","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(06)68653-4","article-title":"Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm","volume":"367","author":"Bethony","year":"2006","journal-title":"Lancet"},{"key":"2020081004280604600_CIT0002","doi-asserted-by":"crossref","first-page":"e1608","DOI":"10.1371\/journal.pntd.0001608","article-title":"Increased birth weight associated with regular pre-pregnancy deworming and weekly iron-folic acid supplementation for Vietnamese women","volume":"6","author":"Passerini","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004280604600_CIT0003","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"Keiser","year":"2008","journal-title":"JAMA"},{"key":"2020081004280604600_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60069-X","article-title":"Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance","volume":"35","author":"Conder","year":"1995","journal-title":"Adv Parasitol"},{"key":"2020081004280604600_CIT0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/CMR.13.2.207","article-title":"Drug resistance in human helminths: current situation and lessons from livestock","volume":"13","author":"Geerts","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"2020081004280604600_CIT0006","doi-asserted-by":"crossref","first-page":"e0005574","DOI":"10.1371\/journal.pntd.0005574","article-title":"Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults","volume":"11","author":"Diemert","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004280604600_CIT0007","doi-asserted-by":"crossref","first-page":"B227","DOI":"10.1016\/j.vaccine.2012.11.034","article-title":"The human hookworm vaccine","volume":"31","author":"Hotez","year":"2013","journal-title":"Vaccine"},{"key":"2020081004280604600_CIT0008","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2011.03.026","article-title":"Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths","volume":"29","author":"Alexander","year":"2011","journal-title":"Vaccine"},{"key":"2020081004280604600_CIT0009","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13071-015-0994-z","article-title":"Identification of human intestinal parasites affecting an asymptomatic peri-urban Argentinian population using multi-parallel quantitative real-time polymerase chain reaction","volume":"8","author":"Cimino","year":"2015","journal-title":"Parasit Vectors"},{"key":"2020081004280604600_CIT0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.12-0726","article-title":"A novel, multi-parallel, real-time polymerase chain reaction approach for eight gastrointestinal parasites provides improved diagnostic capabilities to resource-limited at-risk populations","volume":"88","author":"Mejia","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"2020081004280604600_CIT0011","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2222.2009.03187.x","article-title":"Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study","volume":"39","author":"Feary","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"2020081004280604600_CIT0012","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2222.2009.03433.x","article-title":"Experimental hookworm infection: a randomized placebo-controlled trial in asthma","volume":"40","author":"Feary","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"2020081004280604600_CIT0013","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4269\/ajtmh.2006.75.914","article-title":"Dose-ranging study for trials of therapeutic infection with Necator americanus in humans","volume":"75","author":"Mortimer","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2020081004280604600_CIT0014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4269\/ajtmh.1984.33.387","article-title":"Larvicidal activity of albendazole against Necator americanus in human volunteers","volume":"33","author":"Cline","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"2020081004280604600_CIT0015","doi-asserted-by":"crossref","first-page":"e17366","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease\u2013a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS One"},{"key":"2020081004280604600_CIT0016","doi-asserted-by":"crossref","first-page":"e1002520","DOI":"10.1371\/journal.ppat.1002520","article-title":"Characterising the mucosal and systemic immune responses to experimental human hookworm infection","volume":"8","author":"Gaze","year":"2012","journal-title":"PLoS Pathog"},{"key":"2020081004280604600_CIT0017","doi-asserted-by":"crossref","first-page":"e24092","DOI":"10.1371\/journal.pone.0024092","article-title":"Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection","volume":"6","author":"McSorley","year":"2011","journal-title":"PLoS One"},{"key":"2020081004280604600_CIT0018","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4269\/ajtmh.1987.37.126","article-title":"The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection","volume":"37","author":"Maxwell","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"2020081004280604600_CIT0019","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.2005.079129","article-title":"A proof of concept study establishing Necator americanus in Crohn\u2019s patients and reservoir donors","volume":"55","author":"Croese","year":"2006","journal-title":"Gut"},{"key":"2020081004280604600_CIT0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2006.05.019","article-title":"Allergy controls the population density of Necator americanus in the small intestine","volume":"131","author":"Croese","year":"2006","journal-title":"Gastroenterology"},{"key":"2020081004280604600_CIT0021","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0020-7519(92)90003-4","article-title":"The partial characterization of proteases present in the excretory\/secretory products and exsheathing fluid of the infective (L3) larva of Necator americanus","volume":"22","author":"Kumar","year":"1992","journal-title":"Int J Parasitol"},{"key":"2020081004280604600_CIT0022","volume-title":"Diagnosing Helminthiasis Through Coprological Examination","author":"Thienpont","year":"1979"},{"key":"2020081004280604600_CIT0023","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2020081004280604600_CIT0024","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0031182000074953","article-title":"Observations on the feeding behaviour of parasitic third-stage hookworm larvae","volume":"106","author":"Hawdon","year":"1993","journal-title":"Parasitology"},{"key":"2020081004280604600_CIT0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2249.2005.02945.x","article-title":"Immune responses following experimental human hookworm infection","volume":"142","author":"Wright","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2020081004280604600_CIT0026","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.exppara.2003.12.016","article-title":"Necator americanus: maintenance through one hundred generations in golden hamsters (Mesocricetus auratus). II. Morphological development of the adult and its comparison with humans","volume":"105","author":"Jian","year":"2003","journal-title":"Exp Parasitol"},{"key":"2020081004280604600_CIT0027","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11940-014-0296-3","article-title":"Helminth\/parasite treatment of multiple sclerosis","volume":"16","author":"Correale","year":"2014","journal-title":"Curr Treat Options Neurol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/5\/ofy083\/33591359\/ofy083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/5\/ofy083\/33591359\/ofy083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:29:49Z","timestamp":1597048189000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy083\/4976553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofy083","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,4,19]]},"article-number":"ofy083"}}